Plasma biomarkers for monitoring brain pathophysiology in FMR1 premutation carriers

by Cecilia Giulivi, Cecilia Giulivi, Eleonora Napoli, Flora Tassone, Flora Tassone, Julian Halmai, Randi Hagerman, Randi Hagerman
Published 2016-08-01

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder

by Reem Rafik Alolaby, Poonnada Jiraanont, Blythe Durbin-Johnson, Mittal Jasoliya, Hiu-Tung Tang, Randi Hagerman, Randi Hagerman, Flora Tassone, Flora Tassone
Published 2020-04-01

Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins

by Eleonora Napoli, Andrea Schneider, Andrea Schneider, Randi Hagerman, Randi Hagerman, Gyu Song, Sarah Wong, Flora Tassone, Flora Tassone, Cecilia Giulivi, Cecilia Giulivi
Published 2018-08-01

Fragile X syndrome and fragile X-associated disorders [version 1; referees: 2 approved]

by Akash Rajaratnam, Jasdeep Shergill, Maria Salcedo-Arellano, Wilmar Saldarriaga, Xianlai Duan, Randi Hagerman
Published 2017-12-01

Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.

by Milo Careaga, Destanie Rose, Flora Tassone, Robert F Berman, Randi Hagerman, Paul Ashwood
Published 2014-01-01

Altered Redox Mitochondrial Biology in the Neurodegenerative Disorder Fragile X-Tremor/Ataxia Syndrome: Use of Antioxidants in Precision Medicine

by Gyu Song, Eleonora Napoli, Sarah Wong, Randi Hagerman, Siming Liu, Flora Tassone, Cecilia Giulivi
Published 2016-06-01

Fragile X syndrome and associated disorders: Clinical aspects and pathology

by Maria Jimena Salcedo-Arellano, Brett Dufour, Yingratana McLennan, Veronica Martinez-Cerdeno, Randi Hagerman
Published 2020-03-01

Developmental aspects of FXAND in a man with the FMR1 premutation

by Ellery Santos, Chinelo Emeka‐Nwonovo, Jun Yi Wang, Andrea Schneider, Flora Tassone, Paul Hagerman, Randi Hagerman
Published 2020-02-01

Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome

by Mittal Jasoliya, Heather Bowling, Ignacio Cortina Petrasic, Blythe Durbin-Johnson, Eric Klann, Aditi Bhattacharya, Randi Hagerman, Flora Tassone
Published 2020-06-01

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism

by Xiao-Hong Wang, Xiao-Hong Wang, Jin-Chen Yang, Jin-Chen Yang, Robert Soohoo, Robert Soohoo, Devyn Cotter, Devyn Cotter, Mei Yuan, Mei Yuan, Jiangyi Xia, Shuja Yaqub, Jesse Doty, Yu-Qiong Niu, Yu-Qiong Niu, Flora Tassone, Flora Tassone, Randi Hagerman, Randi Hagerman, Lin Zhang, John Olichney, John Olichney
Published 2018-09-01

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

by Randi Hagerman, Sebastien Jacquemont, Elizabeth Berry-Kravis, Vincent Des Portes, Andrew Stanfield, Barbara Koumaras, Gerd Rosenkranz, Alessandra Murgia, Christian Wolf, George Apostol, Florian von Raison
Published 2018-11-01

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis

by Skylar Luu, Haley Province, Elizabeth Berry-Kravis, Randi Hagerman, David Hessl, Dhananjay Vaidya, Reymundo Lozano, Hilary Rosselot, Craig Erickson, Walter E. Kaufmann, Dejan B. Budimirovic
Published 2020-09-01

Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

by Angela John Thurman, Laura A. Potter, Kyoungmi Kim, Flora Tassone, Amy Banasik, Sarah Nelson Potter, Lauren Bullard, Vivian Nguyen, Andrea McDuffie, Randi Hagerman, Leonard Abbeduto
Published 2020-04-01

Arbaclofen in fragile X syndrome: results of phase 3 trials

by Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, Dejan Budimirovic, Walter E. Kaufmann, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Paul Wang, Mark F. Bear, Randall L. Carpenter
Published 2017-06-01